Complete financial analysis of Medical Cannabis Payment Solutions, Inc. (REFG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medical Cannabis Payment Solutions, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Argo Blockchain plc (ARBKF) Income Statement Analysis – Financial Results
- China Water Affairs Group Limited (CWAFF) Income Statement Analysis – Financial Results
- ORIX Corporation (IX) Income Statement Analysis – Financial Results
- Newag S.A. (NWG.WA) Income Statement Analysis – Financial Results
- Nanning Chemical Industry Co., Ltd. (600301.SS) Income Statement Analysis – Financial Results
Medical Cannabis Payment Solutions, Inc. (REFG)
About Medical Cannabis Payment Solutions, Inc.
Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 21.92K | 21.92K | 12.66K | 2.84K | 0.00 | 0.00 | 0.00 | 1.04K |
| Gross Profit | -21.92K | -21.92K | -12.66K | -2.84K | 0.00 | 0.00 | 0.00 | -1.04K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 120.00K | 0.00 | 332.60K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 289.72K | 136.58K | 7.20K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.94M | 373.07K | 385.21K |
| SG&A | 12.18K | 1.61M | 496.37K | 230.40K | 340.71K | 4.23M | 509.65K | 392.41K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 12.18K | 1.73M | 496.37K | 563.00K | 340.71K | 4.23M | 509.65K | 392.41K |
| Cost & Expenses | 34.10K | 1.75M | 509.03K | 565.84K | 340.71K | 4.23M | 509.65K | 393.45K |
| Interest Income | 0.00 | 0.00 | 185.27K | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 420.00 | 10.03K | 1.15K | 1.00K | 0.00 | 0.00 | 5.50K |
| Depreciation & Amortization | 21.92K | 21.92K | 12.66K | 2.84K | 161.14K | 2.69K | 2.69K | 1.04K |
| EBITDA | -12.18K | -1.59M | -311.11K | -563.00K | -1.34M | -4.23M | -509.65K | -392.41K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -34.10K | -1.75M | -509.03K | -565.84K | -340.71K | -4.23M | -509.65K | -393.45K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.00 | 143.66K | 175.24K | -261.03K | -1.00M | 0.00 | -5.50K | -5.50K |
| Income Before Tax | -34.10K | -1.61M | -333.79K | -826.86K | -1.34M | -4.23M | -509.65K | -398.95K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 3.00 | 2.00 | -185.27K | 259.87K | -161.14K | -63.16K | -2.69K | -3.00 |
| Net Income | -34.10K | -1.61M | -333.79K | -826.86K | -1.34M | -4.23M | -509.65K | -398.95K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | 0.00 |
| Weighted Avg Shares Out | 608.38M | 608.38M | 544.09M | 473.47M | 458.46M | 240.59M | 31.93M | 145.92M |
| Weighted Avg Shares Out (Dil) | 608.38M | 608.38M | 544.09M | 473.47M | 458.46M | 240.59M | 31.93M | 145.92M |
No news found for: REFG
Source: https://incomestatements.info
Category: Stock Reports